Pfizer’s most recent trend suggests a bullish bias. One trading opportunity on Pfizer is a Bull Put Spread using a strike $50.50 short put and a strike $45.00 long put offers a potential 25.86% return on risk over the next 22 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $50.50 by expiration. The full premium credit of $1.13 would be kept by the premium seller. The risk of $4.37 would be incurred if the stock dropped below the $45.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Pfizer is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Pfizer is bullish.
The RSI indicator is at 73.29 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Pfizer
How This News May Represent a Crucial Test for Moderna and Pfizer
Wed, 24 Nov 2021 11:30:00 +0000
Health regulators initially weren’t jumping to authorize coronavirus booster shots. This summer, they considered current vaccines offered necessary protection. Still, earlier this fall, they decided to authorize the shots — but only for certain individuals rather than for broad use.
Will Pfizer ETFs Soar on Positive COVID-19 Vaccine Updates?
Tue, 23 Nov 2021 23:00:11 +0000
Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging updates in the coronavirus vaccine.
COVID-19 vaccines have ‘proved their merit at this point’: Doctor
Tue, 23 Nov 2021 21:30:51 +0000
Dr. David Katz, Preventive Medicine Specialist & True Health Initiative President, joins Yahoo Finance Live to discuss the latest in the coronavirus pandemic.
Countries pushing vaccine IP waivers ‘want to take advantage of the technology’: Fmr. U.S. Commerce Secretary
Tue, 23 Nov 2021 16:55:38 +0000
Former U.S. Commerce Secretary and Former Washington Governor Gary Locke joins Yahoo Finance Live to discuss travel warnings to Germany and Denmark as COVID-19 cases are rising, the push get more vaccinated in developing countries, and the impact of Trump’s tariffs on Chinese goods.
COVID-19: The U.S. issues advisory for travel to Europe but has no plans for a lockdown
Tue, 23 Nov 2021 15:26:31 +0000
Yahoo Finance’s Anjalee Khemlani joins the Live show to discuss how U.S. officials are reacting to COVID-19 case surges in Europe, where countries are mandating their own lockdowns and vaccine procedures.
Follow Us on Facebook